Skip to main content

Anti Microbial Resistance

Share:

Antimicrobial resistance, or AMR, is a top ten public health threat (1).

In 2018, approximately 26% of infection-causing microbes exhibited resistance to antimicrobials used to treat them in Canada. This was estimated to result in 5,400 deaths and a 1.4 billion dollar healthcare bill that year.

Projected trends suggest resistance could escalate to 40% by 2050, contributing to a yearly estimate of 13,700 deaths and a 7.6 billion dollar impact on our healthcare system (6,24).

An increase in #AMR would also further increase (6,24):

  • Inequity and inequality: Children, older adults, people living in overcrowded and/or poor housing conditions, Indigenous populations, and new Canadians are more at risk to suffer from an increase in AMR
  • Stigma and discrimination: Being affected by AMR unequally, some social groups will face greater infection rates and thus could be the target of stigma and discrimination due to fear of infections.

Our best chance at slowing the spread of resistance is to first prevent infections, then avoid using antimicrobials unless it is necessary, and finally to always follow the full course of treatment* when we do use them.

You can also share this post with your friends, so that they too are aware of the challenges AMR represents for our future.

 

* Duration of antimicrobials courses have become shorter than they have been in the past, as they have been shown to be just as effective but with fewer side effects. It is a good idea to discuss with your prescriber and pharmacist about the most appropriate approach.

Share our original Tweet!

View our original Instagram Post!

 
 
 
 
 
View this post on Instagram
 
 
 
 
 
 
 
 
 
 
 

 

A post shared by ScienceUpFirst (@scienceupfirst)

Sources
  1. Antibiotic Awareness | FR : Semaine mondiale de sensibilisation aux antimicrobiens
  2. Data Note: Public Awareness Around Antibiotic Resistance
  3. About antibiotics | FR : À propos des antibiotiques
  4. Antimicrobial resistance | FR : Principaux repères sur la résistance aux antimicrobiens  
  5. Antimicrobials, Antimicrobial Resistance and Antimicrobial Stewardship
  6. When Antibiotics Fail | FR : Quand les antibiotiques échouent
  7. About antibiotic resistance | FR : À propos de la résistance aux antibiotiques
  8. Antimicrobial Resistance – Overview | FR : Résistance aux antimicrobiens : aperçu
  9. Pan-Canadian Action Plan on Antimicrobial Resistance | FR : Plan d’action pancanadien sur la résistance aux antimicrobiens
  10. Antibiotic resistance and risks to human health | FR : Résistance aux antibiotiques et risques pour la santé humaine
  11. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
  12. Impact of antibiotics on the human microbiome and consequences for host health
  13. Does your child have an earache? | FR : Votre enfant souffre-t-il d’une otite?
  14. Let’s talk… – Ear Infection | FR : Parlons.. D’infection de l’oreille
  15. Acute otitis media
  16. Acute Otitis Media
  17. Management of acute otitis media in children six months of age and older
  18. Watchful Waiting for Acute Otitis Media
  19. Original Article Amoxicillin Versus Other Antibiotic Agents for the Treatment of Acute Otitis Media in Children
  20. Adverse Events of Antibiotics Used to Treat Acute Otitis Media in Children: A Systematic Meta-Analysis
  21. Urinary Tract Infections | FR : Les infections des voies urinaires
  22. Urinary Tract Infections | FR : L’infection urinaire – Symptômes, causes et traitement
  23. Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment
  24. Community-onset urinary tract infections: a population-based assessment
  25. When Antibiotic Fail – Infographic | FR : Quand les antibiotiques échouent – Infographie
  26. Urinary Tract Infections in Teenagers and Adults
  27. Pattern of Antibacterial Resistance in Urinary Tract Infections: A Systematic Review and Meta-analysis
  28. State of the Globe: Rising Antimicrobial Resistance of Pathogens in Urinary Tract Infection
  29. Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study
  30. Guidelines for the diagnosis and management of recurrent urinary tract infection in women
  31. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women
  32. Antibiotic Prophylaxis in Obstetric Procedures
  33. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
  34. Duration of antibiotic therapy for common infections
  35. Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action | FR : Lutter contre la résistance aux antimicrobiens et optimiser leur utilisation : un cadre d’action pancanadien
  36. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations